A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
about
Clozapine: a review of clinical practice guidelines and prescribing trendsRefractory schizophrenia and atypical antipsychoticsRisperidone versus other atypical antipsychotics for schizophreniaOlanzapine versus other atypical antipsychotics for schizophreniaClozapine combined with different antipsychotic drugs for treatment resistant schizophreniaPharmacologic treatment of schizophreniaApplication of a disease-specific mapping function to estimate utility gains with effective treatment of schizophreniaOn the Complexity of Brain Disorders: A Symptom-Based Approach.Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.Carbamazepine for schizophrenia and schizoaffective psychoses.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.Atypical antipsychotics: Part II: Adverse effects, drug interactions, and costs.Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.Clozapine in community practice: a 3-year follow-up study in the Australian Capital Territory.Hospital days in risperidone-treated patients.Conventional versus novel antipsychotics: changing concepts and clinical implicationsThe efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variationDrug treatments for schizophreniaAssociation study of DTNBP1 with schizophrenia in a US sample.Effectiveness of clozapine in treatment-resistant schizophrenia.Dirichlet Component Regression and its Applications to Psychiatric Data.Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapineThe new atypical antipsychotics: a review of pharmacoeconomic studies.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial.Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.Methodological issues in current antipsychotic drug trials.Pharmacotherapy for treatment-resistant schizophrenia.Treatment of the special patient with schizophrenia.Quality of life in schizophrenic patients.Atypical Antipsychotic Use in the Treatment of Psychosis in Primary CareNew antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?Clozapine prescribing in the UK: views and experience of consultant psychiatrists.QUALITY-CONSTANT "PRICES" FOR THE ONGOING TREATMENT OF SCHIZOPHRENIA: AN EXPLORATORY STUDY*Pharmacological treatment strategies for schizophrenia.Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics.Mental health policy and psychotropic drugsDoes lack of improvement in the first two weeks predict treatment resistance in recent-onset psychosis?Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
P2860
Q21260307-E0B01DB3-CDF7-48F2-8D47-349E80EE128AQ22241831-BE8DAD8F-B9D3-4371-B3FB-C32D41CCD0F3Q24234950-CC09D85F-10E1-4937-8222-8337F82DD05AQ24236545-BFA552CA-BDDD-4835-B3D6-DC04CF1CE3FFQ24240093-B90120BA-BB64-4404-971C-CE1DEF77EE23Q24604457-8862C292-11FB-4AE3-87A2-E56A1325B9A7Q24815361-09C4FF06-6C53-4056-843A-27DD1564BB81Q30389213-DC37B65F-70F4-4A34-8236-2E0CB77CC8D3Q30501297-06893841-7FD7-413B-892E-B7DB0441030FQ30838723-3D5B9A54-CDAF-492C-BB28-30EB56018BC0Q33223628-7470752F-2458-4EE7-9F3B-B8216B147A48Q33235110-8205C7DF-317D-48CA-A9BB-08D9404E9FA1Q33543117-D1E643A8-7A11-42DF-9600-0360001B34D2Q33726559-F0BDE9E7-BC3D-45EF-AF92-D61A65E74895Q33764255-6D941DD7-6891-4627-BF4F-0FA87F1BB9F9Q33786061-AB4C60A6-CADE-463C-AD63-D885F1F3349BQ33787546-BF1925CA-919C-48B7-8EA4-C8BCA276D05EQ33802672-286E6588-0BD6-419C-87D5-693D2E314794Q33940113-23B9EE5B-7D67-4F90-B932-784D909EAEE6Q34019925-D82CB8E5-0D50-4A56-97C7-DB76842BA1F6Q34052480-CBEA20D8-87EF-4EF1-A340-0248EBB46543Q34068519-DC81F049-D92E-4260-AB6D-C45958DDE5E4Q34129991-B98EB8DB-DA3B-4B40-8B6C-7259644C9D0AQ34182242-E9293706-5310-4B20-A54A-B01B4845DCEEQ34315836-B452F1EF-0418-48CE-B793-FA2B2508E820Q34464608-BFDC8DBE-A422-4E5A-8E5E-F6326F9E0F65Q34522634-BC5818AF-426D-482A-8B20-8A64C2EB06B6Q34587745-C86818C3-4467-430D-97D1-2FA95960FC0BQ34879109-F97ACD5A-2EB0-4A90-B61D-B60D0A2B1430Q35236370-044FC53E-3CA9-4CCE-BD6A-EEEA8C80F6FEQ35236921-A318178C-8DFD-446A-B3C6-18CAF1BE95EDQ35665593-51E7E791-5F09-401A-9113-BBEC897012E8Q35805896-5E604539-65FD-43F8-96F5-D00806172D88Q35906545-50361074-1D7A-403B-8EE6-03A82CC42936Q35940973-F1E8DC43-9A39-4350-A813-C9F6EAA356A5Q36107179-44711D34-B965-47B4-A3D1-A0160816407CQ36120821-8B56CF9A-4507-44D0-8370-15A837EE008FQ36165291-A86E4161-214C-4AE7-8A94-849EE20C530AQ36465378-50E03B59-D964-4C07-9BF9-B821B289D165Q36626242-6C8E1D27-72EC-486E-B26A-E2860680116A
P2860
A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
A comparison of clozapine and ...... e in Refractory Schizophrenia.
@en
A comparison of clozapine and ...... e in Refractory Schizophrenia.
@nl
type
label
A comparison of clozapine and ...... e in Refractory Schizophrenia.
@en
A comparison of clozapine and ...... e in Refractory Schizophrenia.
@nl
prefLabel
A comparison of clozapine and ...... e in Refractory Schizophrenia.
@en
A comparison of clozapine and ...... e in Refractory Schizophrenia.
@nl
P2093
P921
P1476
A comparison of clozapine and ...... ne in Refractory Schizophrenia
@en
P2093
Henderson W
Rosenheck R
P304
P356
10.1056/NEJM199709183371202
P407
P577
1997-09-01T00:00:00Z